Internal Medicine, Rheumatology · Beckley, WV
NPI
1992755201
Since 2006
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
421 Carriage Dr
Beckley, WV, 25801
Phone (304) 256-0242
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.9M
140,249 services
Medicare patients, 2024
926
Average age 72
Drug cost, 2024
$12.2M
9,700 prescriptions
Company payments, 2025
$240K
From 20 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Wassim S Saikali was code J0717 (injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)), 75,200 times for 25 patients. In total Wassim S Saikali billed 140,249 services in 65 codes, and Medicare paid $1.9M.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-07-13.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| J0717 Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 75,200 | 25 | $3.61 | $271K |
| J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 12,500 | 22 | $33.92 | $424K |
| J0897 Injection, denosumab, 1 mg | Office | 11,820 | 122 | $20.49 | $242K |
| J3111 Injection, romosozumab-aqqg, 1 mg | Office | 10,920 | 12 | $8.51 | $93K |
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 4,800 | 87 | $0.10 | $480 |
| 99213 Office E&M - Established | Office | 1,036 | 622 | $59.72 | $62K |
| 99214 Office E&M - Established | Office | 872 | 493 | $83.97 | $73K |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 861 | 125 | $0.68 | $587 |
| 96372 Injection Administration | Office | 373 | 25 | $10.57 | $3,941 |
| 20610 Joint Injection | Office | 306 | 154 | $51.92 | $16K |
| 96413 Chemotherapy Administration | Office | 294 | 43 | $89.81 | $26K |
| J3489 Injection, zoledronic acid, 1 mg | Office | 285 | 57 | $4.43 | $1,263 |
| 96401 Chemotherapy Administration | Office | 256 | 136 | $47.56 | $12K |
| 77080 Standard X-ray | Office | 117 | 117 | $35.40 | $4,141 |
| 99203 Office E&M - New | Office | 104 | 104 | $76.77 | $7,984 |
By year: 2022 $2.0M for 136,350 services; 2023 $1.5M for 140,216 services; 2024 $1.9M for 140,249 services.
Medicare prescription drug claims, 2024
In 2024, the drug Wassim S Saikali prescribed most often to Medicare patients was Hydroxychloroquine Sulfate, with 1,451 prescriptions and refills. In total Wassim S Saikali wrote 9,700 Medicare prescriptions that cost $12.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydroxychloroquine Sulfate Generic | 1,451 | 3,475 | 407 | $62K |
| Prednisone Generic | 902 | 1,581 | 303 | $4,904 |
| Methotrexate Methotrexate Sodium | 790 | 1,809 | 209 | $17K |
| Alendronate Sodium Generic | 559 | 1,214 | 179 | $4,071 |
| Tramadol Hcl Generic | 454 | 456 | 54 | $2,379 |
| Gabapentin Generic | 443 | 443 | 53 | $2,811 |
| Enbrel Sureclick Etanercept | 353 | 365 | 43 | $2.7M |
| Duloxetine Hcl Generic | 350 | 784 | 103 | $4,438 |
| Celecoxib Generic | 345 | 758 | 106 | $11K |
| Humira(Cf) Pen Adalimumab | 310 | 339 | 38 | $2.5M |
| Pantoprazole Sodium Generic | 250 | 646 | 84 | $2,564 |
| Meloxicam Generic | 220 | 579 | 81 | $1,198 |
| Allopurinol Generic | 218 | 547 | 54 | $2,265 |
| Omeprazole Generic | 213 | 582 | 67 | $2,020 |
| Pilocarpine Hcl Generic | 160 | 329 | 57 | $11K |
Brand drugs: - claims; generic drugs: 8,113 claims; opioid claims: 504.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Wassim S Saikali $240K ($240K in general payments such as food, travel and fees) from 20 companies. The largest payer was Abbvie Inc. with $70K.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 97 | $70K |
| ANI Pharmaceuticals, Inc. ANIP | 81 | $60K |
| Amgen Inc. AMGN | 76 | $39K |
| UCB, Inc. UCB.BR | 57 | $27K |
| AstraZeneca Pharmaceuticals LP AZN | 20 | $17K |
| Novartis Pharmaceuticals Corporation NVS | 14 | $9,257 |
| Mallinckrodt Hospital Products Inc. | 7 | $9,180 |
| GlaxoSmithKline, LLC. GSK | 6 | $6,074 |
| Janssen Biotech, Inc. JNJ | 3 | $2,336 |
| Genzyme Corporation SNY | 1 | $97.69 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.